Within‐lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis

To investigate the relationship between quantitative magnetic resonance imaging (qMRI) and contrast enhancement in multiple sclerosis (MS) lesions. We compared maps of T1 relaxation time, proton density (PD), and magnetization transfer ratio (MTR) between lesions with and without contrast enhancement as quantified by the amount of T1 shortening postcontrast agent (CA).

[1]  R. Ordidge,et al.  High field MRI correlates of myelin content and axonal density in multiple sclerosis , 2003, Journal of Neurology.

[2]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[3]  J. Olesen,et al.  In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis , 1988, Magnetic resonance in medicine.

[4]  S. McQuaid,et al.  Persistent endothelial abnormalities and blood–brain barrier leak in primary and secondary progressive multiple sclerosis , 2007, Neuropathology and applied neurobiology.

[5]  J. Taubenberger,et al.  Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis , 1993, Annals of neurology.

[6]  P. Lundberg,et al.  Novel method for rapid, simultaneous T1, T*2, and proton density quantification , 2007, Magnetic resonance in medicine.

[7]  F. Barkhof.  The clinico‐radiological paradox in multiple sclerosis revisited , 2002, Current opinion in neurology.

[8]  Thomas G. Maris,et al.  Quantification of magnetization transfer rate and native T1 relaxation time of the brain: correlation with magnetization transfer ratio measurements in patients with multiple sclerosis , 2005, Neuroradiology.

[9]  David H. Miller,et al.  Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain , 2004, Annals of neurology.

[10]  F. Barkhof,et al.  Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter. , 2006, Radiology.

[11]  B. Scheithauer,et al.  Inflammatory cortical demyelination in early multiple sclerosis. , 2011, The New England journal of medicine.

[12]  F. Barkhof,et al.  Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability , 1999, Annals of neurology.

[13]  Alan J Thompson,et al.  TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis , 2010, Multiple sclerosis.

[14]  David H. Miller,et al.  The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis , 2002, Journal of Neurology.

[15]  C. Lucchinetti,et al.  Meningeal and cortical grey matter pathology in multiple sclerosis , 2012, BMC Neurology.

[16]  Frederik Barkhof,et al.  Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis. , 2009, Archives of neurology.

[17]  Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. , 2002, Brain pathology.

[18]  Ludwig Kappos,et al.  Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis , 1999, The Lancet.

[19]  David H. Miller,et al.  Normal-appearing brain t1 relaxation time predicts disability in early primary progressive multiple sclerosis. , 2007, Archives of neurology.

[20]  R. Deichmann,et al.  T1 mapping using spoiled FLASH‐EPI hybrid sequences and varying flip angles , 2009, Magnetic resonance in medicine.

[21]  R. Bakshi,et al.  Multiple sclerosis: hyperintense lesions in the brain on nonenhanced T1-weighted MR images evidenced as areas of T1 shortening. , 2007, Radiology.

[22]  MTR and T1 provide complementary information in MS NAWM, but not in lesions , 2000, Multiple sclerosis.

[23]  D. N. Landon,et al.  The characterization of experimental gliosis by quantitative nuclear magnetic resonance imaging. , 1988, Brain : a journal of neurology.

[24]  E M Haacke,et al.  Accurate determination of spin‐density and T1 in the presence of RF‐field inhomogeneities and flip‐angle miscalibration , 1998, Magnetic resonance in medicine.

[25]  Wolfgang Brück,et al.  Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. , 2002, Brain : a journal of neurology.

[26]  W. Mcdonald,et al.  The longstanding MS lesion. A quantitative MRI and electron microscopic study. , 1991, Brain : a journal of neurology.

[27]  G J Barker,et al.  Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities , 2003, Multiple sclerosis.

[28]  P M Matthews,et al.  MRI Brain T1 Relaxation Time Changes in MS Patients Increase Over Time in Both the White Matter and the Cortex , 2003, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[29]  Ralf Deichmann,et al.  A fast B1-mapping method for the correction and normalization of magnetization transfer ratio maps at 3 T , 2010, NeuroImage.

[30]  Hans Lassmann,et al.  Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology , 1997, Annals of neurology.

[31]  F. Barkhof,et al.  Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis , 1998, Neurology.

[32]  Marco Sinisi,et al.  Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy , 2007, BMC neurology.

[33]  R. Deichmann,et al.  Correction of systematic errors in quantitative proton density mapping , 2012, Magnetic resonance in medicine.

[34]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[35]  V. Perry,et al.  Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.

[36]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[37]  J. Berman,et al.  Myelin basic protein induces inflammatory mediators from primary human endothelial cells and blood–brain barrier disruption: implications for the pathogenesis of multiple sclerosis , 2013, Neuropathology and applied neurobiology.

[38]  Ralf Deichmann,et al.  Improvement of the image quality of T1-weighted anatomical brain scans , 2006, NeuroImage.

[39]  R. Deichmann,et al.  Influence of RF spoiling on the stability and accuracy of T1 mapping based on spoiled FLASH with varying flip angles , 2009, Magnetic resonance in medicine.

[40]  P. Matthews,et al.  White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis , 2002, Journal of Neurology.

[41]  A. J. Thompson,et al.  Increasing normal–appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing–remitting multiple sclerosis , 2005, Journal of Neurology.